Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme.
about
Fragment-based screening by X-ray crystallography, MS and isothermal titration calorimetry to identify PNMT (phenylethanolamine N-methyltransferase) inhibitorsIdentification of a 3-aminoimidazo[1,2-a]pyridine inhibitor of HIV-1 reverse transcriptase.SJP-L-5, a novel small-molecule compound, inhibits HIV-1 infection by blocking viral DNA nuclear entry.Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise.2-(4-Meth-oxy-phen-yl)-1-phenyl-1H-benzimidazoleCombined Pd/C and Montmorillonite Catalysis for One-Pot Synthesis of Benzimidazoles.Comprehensive Review in Current Developments of Benzimidazole-Based Medicinal Chemistry.Novel fluorine-containing DAPY derivatives as potent HIV-1 NNRTIs: a patent evaluation of WO2014072419.Efficient aerobic oxidative synthesis of 2-substituted benzoxazoles, benzothiazoles, and benzimidazoles catalyzed by 4-methoxy-TEMPO.One-pot strategy of copper-catalyzed synthesis of 1,2-disubstituted benzimidazoles.Novel Mcl-1/Bcl-2 dual inhibitors created by the structure-based hybridization of drug-divided building blocks and a fragment deconstructed from a known two-face BH3 mimetic.From TIBO to Rilpivirine: The Chronicle of the Discovery of the Ideal Nonnucleoside Reverse Transcriptase Inhibitor
P2860
Q27663569-3862049A-885E-43EC-B3AD-6C06C6A39859Q34508801-716AF1EC-5691-45E5-9512-91B7FC6E6D7BQ35859394-04BC0B7D-0C9B-4164-B1D2-242D69E22B1FQ36435971-8E660C92-CF12-4234-85D4-208AFDCBDCA2Q36602566-7F9991B9-A0CD-48E7-BFC9-37A89F8E97CDQ36697696-84D5675B-55C3-49FA-BC18-0F7527D672A3Q38263434-CA976C97-8F22-4C71-BF32-BF003614258DQ40977182-9830BA0C-AAE6-4841-83B7-C084F45316D1Q46274526-88CC5FA4-F34D-4A4A-863D-AD9E464491B9Q47975744-ADB1F682-60AA-463E-AC20-D91F6F9A8E1FQ52970803-F6E903BB-291A-4FCB-AC8F-3FDE4DCA2249Q56786251-EE3A0D38-235A-45B6-B479-058A98F8F609
P2860
Synthesis, biological activity, and crystal structure of potent nonnucleoside inhibitors of HIV-1 reverse transcriptase that retain activity against mutant forms of the enzyme.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Synthesis, biological activity ...... st mutant forms of the enzyme.
@ast
Synthesis, biological activity ...... st mutant forms of the enzyme.
@en
Synthesis, biological activity ...... st mutant forms of the enzyme.
@nl
type
label
Synthesis, biological activity ...... st mutant forms of the enzyme.
@ast
Synthesis, biological activity ...... st mutant forms of the enzyme.
@en
Synthesis, biological activity ...... st mutant forms of the enzyme.
@nl
prefLabel
Synthesis, biological activity ...... st mutant forms of the enzyme.
@ast
Synthesis, biological activity ...... st mutant forms of the enzyme.
@en
Synthesis, biological activity ...... st mutant forms of the enzyme.
@nl
P2093
P2860
P356
P1476
Synthesis, biological activity ...... st mutant forms of the enzyme.
@en
P2093
Christopher J Michejda
David W Farnsworth
Eddy Arnold
John G Julias
Kalyan Das
Karen Watson
Marilyn Kroeger Smith
Marshall L Morningstar
Robert W Buckheit
Thomas Roth
P2860
P304
P356
10.1021/JM060103D
P407
P577
2007-07-31T00:00:00Z